Abbott Labs Posts Strong First-Quarter Growth

abbott laboratories earningsAbbott Laboratories reported higher earnings from continuing operations, as demand for its nutritional and diagnostic products offset declining sales of the company's medical devices.

Abbott Laboratories Inc. (ABT), which split off its branded drugs business at the beginning of the year into a new company called AbbVie Inc. (ABBV), on Wednesday reported a first-quarter profit of $544 million, or 34 cents a share, from continuing operations.

That compared with year-earlier earnings from continuing operations of $351 million, or 22 cents a share.

Excluding special items, the suburban Chicago company earned 42 cents a share. Analysts, on average, had expected 41 cents a share, according to Thomson Reuters I/B/E/S.

Sales rose 1.8 percent to $5.38 billion, slightly below Wall Street expectations of $5.41 billion.
Read Full Story

Markets

DJIA 21,012.42 74.51 0.36%
NASDAQ 6,163.02 24.31 0.40%
S&P 500 2,404.39 5.97 0.25%
NIKKEI 225 19,829.38 86.40 0.44%
HANG SENG 25,650.21 221.71 0.87%
DAX 12,642.87 -16.28 -0.13%
USD (per EUR) 1.12 0.00 0.08%
USD (per CHF) 0.97 0.00 -0.03%
JPY (per USD) 111.65 0.13 0.12%
GBP (per USD) 1.30 0.00 0.09%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.